Hidradenitis Suppurativa
Conditions
Keywords
Hidradenitis Suppurativa
Brief summary
This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old * Diagnosis of hidradenitis suppurativa * Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion criteria
* Female patients who are currently pregnant or nursing * Inability to perform regular electronic reporting * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of hidradenitis suppurativa patients who decide to enroll in a clinical research | 3 months |
| Rate of hidradenitis suppurativa patients who remain in clinical trial to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed